The loss of skeletal muscle mass and function is defined as sarcopenia, which might
develop in elderly patients with cancers. It has been indicated as a potential negative factor …

Background Esophagectomy is the gold-standard treatment for locally advanced
esophageal cancer but has high morbimortality rates. Sarcopenia is a common comorbidity …

Background: Surgeons have historically used age as a preoperative predictor of
postoperative outcomes. Sarcopenia, the loss of skeletal muscle mass due to disease or …

Background In recent years, the research on the relationship between sarcopenia before
and after the treatment of esophageal cancer, as well as its impact on prognosis of …

Background Considerable controversies exist regarding the severity of skeletal muscle
wasting (SMW) during neoadjuvant therapy (NAT) and its impact on therapeutic outcomes in …

Objectives The objective of this study is to investigate whether the evaluation of
postoperative outcomes or overall survival in patients who undergo surgery for esophageal …

Purpose Esophageal cancer is a lethal tumor typically treated by neoadjuvant chemotherapy
and surgery. For patients undergoing esophagectomy, postoperative enteral nutrition is …

The prognostic role of pretreatment skeletal muscle mass index (SMI) has been verified in
several types of cancers. However, it remains unclear whether pretreatment SMI is a …

Supplementary Table 2. List of included studies with declared funding sources. Study Funding
Source/Disclosures Aby et al. Achim et al. Agalar et al. Alwani et al. AB reports grants from V …